Company
Technology
Products and Services
News
Investor
Relations
Contact
CE marking of the DiaGenics blood test for early breast cancer diagnosis
DiaGenic to provide MCI biomarkers for Merz Pharmaceuticals
CE marking of the first blood test for early Alzheimers diagnosis
Presentation of the first quarter report 2009
Annual Report for 2008
Profile
Strategy
Management
Board of Directors
Employment
DiaGenic's Concept
Gene Expression Signatures
Diagnostic Platforms
Scientific Literature
Glossary
SAB - Alzheimer's Disease
SAB - Breast Cancer
BCtect™ India
BCtect
®
ADtect
®
Pipeline
Press Releases
DiaGenic in the Media
Events
Press Contacts
Shares and Shareholders
Analysts and Advisors
Financial Reports
Notice to the Oslo Stock Exchange
Analytical Information
Press Releases
Financial Calendar